Rockefeller Capital Management
CRBP icon

Rockefeller Capital Management’s Corbus Pharmaceuticals CRBP Stock Holding History

Rockefeller Capital Management’s Portfolio CRBP Stock Details CRBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-17
Closed – – 3947
2022
Q2 		$0 Hold
17
– – ﹤0.01% 4138
2022
Q1 		$0 Hold
17
– – ﹤0.01% 3892
2021
Q4 		$0 Hold
17
– – ﹤0.01% 3798
2021
Q3 		$0 Hold
17
– – ﹤0.01% 3708
2021
Q2 		$0 Hold
17
– – ﹤0.01% 3458
2021
Q1 		$1K Hold
17
– – ﹤0.01% 3166
2020
Q4 		$0 Hold
17
– – ﹤0.01% 2872
2020
Q3 		$0 Sell
17
-50
-75% -$9.05K ﹤0.01% 2611
2020
Q2 		$17K Hold
67
– – ﹤0.01% 1718
2020
Q1 		$10K Hold
67
– – ﹤0.01% 1735
2019
Q4 		$11K Buy
+67
New +$9.9K ﹤0.01% 1574

Other funds holding CRBP

KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
EMG
ETF Managers Group Summit, New Jersey $3.1B AUM 17.12% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
PA
Pinnacle Associates New York $7.78B AUM 45.07% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $299B AUM 28.69% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Rockefeller Capital Management's CRBP Position: Q3 2022 in Review

Rockefeller Capital Management sold out of Corbus Pharmaceuticals (CRBP) in Q3 2022, closing a stake of 17 shares.

Rockefeller Capital Management first reported a position in CRBP in Q4 2019 and held it in 11 quarters. The position peaked at $17K in Q2 2020. 64 funds tracked by Wall St. Rank hold CRBP as of Q3 2022.

  • Rockefeller Capital Management reported no remaining Corbus Pharmaceuticals position as of Q3 2022 after selling out during the quarter.
  • Rockefeller Capital Management sold 17 Corbus Pharmaceuticals shares in Q3 2022.
  • Rockefeller Capital Management first reported a position in Corbus Pharmaceuticals in Q4 2019 and held it in 11 quarters.
  • Rockefeller Capital Management's Corbus Pharmaceuticals position peaked at $17K in Q2 2020.
  • 64 funds tracked by Wall St. Rank held Corbus Pharmaceuticals as of Q3 2022.

Based on Rockefeller Capital Management's 13F filing for Q3 2022, filed 2 Nov 2022.